Announcement

New product releasing soon.

Auralief Oral Strips BLOOM Arousal Gel    

Investors

Value-Generating Platform

By creating products that customers desire, LOVE Pharma can produce significant value for shareholders.

Corporate Information

LOVE Pharma is a future-looking company in an ever-changing industry, offering innovative products through disruptive technologies that target mental and sexual health.

  • Significant near and mid-term growth catalysts – 7.2% CAGR over the next 10 years (nutraceuticals)
  • Investing in sustainable, long-term revenue with proven products, technologies, and established sales performance
  • Retail ready products for cross-channel promotion to include DTC, brick & mortar, MLM, closed networks, white labeling, and others
  • 6 exclusively licensed technologies
  • Experienced, long-term, drug and nutraceutical team
  • Domestic and international expansion

Capital Structure

Common Shares Outstanding

312,169,945

Options for Common Shares

nil

Warrants for Common Shares (not listed)

73,626,130

Fully Diluted Shares Outstanding

385,796,075

Financials

Financial Statements

Please find the company's financial statements and management discussion and analysis at the issuers profile on SEDAR

Corporate Governance

Legal Counsel

Dentons

Auditor

Baker Tilly

Transfer Agent

Odyssey Trust

Highlights

Oct 2020

Signed initial licensing agreements for novel products

Feb 2020

Closed an initial $2,600,000 CAD in funding

Dec 2020

Signed exclusive licensing partnership with pharmaceutical company

April 2020

Filed patent in partnership with pharmaceutical company for the delivery of psilocybin in a psychedelic mucoadhesive strip

May 2021

Partnered with Potent Ventures to launch Bloom in the US market

Sept 2021

Listed on the Canadian Stock Exchange